Filana Therapeutics (FLNA) Price to Book (2010 - 2026)

Filana Therapeutics has reported Price to Book for 17 years, with the latest figure at 0.9 in Q2 2026.

• On a quarterly basis, Price to Book fell 9.07% year-over-year to 0.9 in Q2 2026; TTM through Jun 2026 was 0.9, a 9.07% decrease from a year earlier, with the FY2025 full-year figure at 1.29, up 64.66% from the prior year.
• Price to Book was 0.9 for Q2 2026 at Filana Therapeutics, down from 1.2 in the prior quarter.
• The five-year high for Price to Book was 11.16 in Q1 2024, with the low at 0.57 in Q1 2025.
• Average Price to Book over 5 years is 4.31, with a median of 4.73 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Price to Book soared 126.18% in 2024, then tumbled 94.91% in 2025.
• Over 5 years, Price to Book stood at 5.42 in 2022, then advanced by 27.65% to 6.92 in 2023, then plunged by 88.71% to 0.78 in 2024, then soared by 64.66% to 1.29 in 2025, then slipped by 29.7% to 0.9 in 2026.
• The last three Price to Book figures came in at 0.9 (Q2 2026), 1.2 (Q1 2026), and 1.29 (Q4 2025), per Business Quant data.